IceCure Medical Ltd. - Ordinary Shares (ICCM)
Healthcare › Surgical & Medical Instruments & Apparatus
Price History
Feb 9, 2026 — May 9, 2026Investment Snapshot
- Trading 59% below Graham Number ($0.59) — significant margin of safety
- Piotroski F-Score 4/9 — moderate financial health
- Loss-making — negative ROE of -66.0%
IceCure Medical Ltd. - Ordinary Shares (ICCM) is a Healthcare company operating in Surgical & Medical Instruments & Apparatus, listed on the NASDAQ , with a market capitalisation of $18 million . Key value metrics: P/E ratio 0.8, P/B ratio 12.33, Piotroski F-Score 4 out of 9 (moderate financial health) .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
IceCure Medical Ltd. - Ordinary Shares — Fundamental Analysis Summary
IceCure Medical Ltd. - Ordinary Shares (ICCM) is trading 59% below its Graham Number of $0.59 — a significant margin of safety by Benjamin Graham's standard. The stock carries a low trailing P/E ratio of 0.8x.
On financial health, ICCM shows a moderate Piotroski F-Score of 4/9, and negative return on equity of -66.0% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.02.
StockPik's composite Value Score for ICCM is 52/100 — an above-average value rating. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
ICCM reports a moderate gross margin of 36.3% (sector average: 40.1%) and a negative operating margin of -446.7%.
ICCM shows revenue growing at 3% year-over-year, with earnings growing at 2%.